CGEN Compugen Ltd
2,608
$2.12
$0.09
(4.07%)
| Watchers | 2,608 |
| 52-Wk Low | $0.53 |
| 52-Wk High | $3.03 |
| Market Cap | $197.86M |
| Volume | 123,719.00 |
| 52-Wk High | $3.03 |
| 52-Wk Low | $0.53 |
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024PR Newswire • 2 days ago
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 PR Newswire HOLON, ISRAEL, May 6, 2024 HOLON, ISRAEL, May...
Share to Feed
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 Compugen to...
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of...
Key Insights Compugen's estimated fair value is US$3.61 based on 2 Stage Free Cash Flow to Equity Compugen's US$2.32...
Compugen Ltd. (NASDAQ:CGEN - Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.57 and traded...
Compugen to Participate in Two Upcoming Investor Conferences Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel, April 3, 2024 HOLON, Israel, April 3, 2024...
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy PR...
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 PR Newswire HOLON...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...